U.S. Government Health Plans Spent Over $1 Billion On EpiPens Over Five Years
U. S. government health plans spent more than $1 billion on Mylan NV’s EpiPen emergency allergic reaction treatment between 2011 and 2015, according to figures released by the Centers for Medicare and Medicaid Services on Wednesday. Mylan is under scrutiny for raising prices on the lifesaving EpiPen sixfold in less than a decade, making the … Read more